How Biofilms Impact UTIs, Interstitial Cystitis, and Chronic Infection with Ruth Kriz, APRN

แชร์
ฝัง
  • เผยแพร่เมื่อ 19 มิ.ย. 2024
  • If you suffer from chronic urinary tract infections, also known as UTIs, or interstitial cystitis, you know how difficult it can be to deal with the symptoms of bladder pain and discomfort. While diets, supplements, and medications are often used, few are aware of the important connection between biofilms and interstitial cystitis.
    Today we are talking with Ruth Kriz all about biofilms and why you should know about them.
    Ruth Kriz is a nurse practitioner who specializes in treating chronic UTI and interstitial cystitis patients. Her interest in biofilms, genetics, and mycotoxins developed through her discovery of an association between those factors and chronic UTIs and interstitial cystitis.
    Please enjoy our conversation that explores the world of biofilms, how they impact our health, and what you can do about biofilms that might be impacting your interstitial cystitis and UTIs.
    Timestamps:
    0:00 - Introduction
    3:10 - How Ruth got interested in biofilms and chronic infections
    8:29 - What are biofilms?
    13:12 - Biofilms and Alzheimer’s
    17:47 - Biofilms, antibiotics and Interstitial Cystitis
    24:24 - Treatments of IC and UTIs
    39:00 - Biofilms and COVID
    45:21 - How bacteria and biofilms interact
    46:15 - Cardiovascular disease and biofilms
    48:43 - Supplements Ruth would bring to a desert island
  • วิทยาศาสตร์และเทคโนโลยี

ความคิดเห็น • 12

  • @vanesaalvarez103
    @vanesaalvarez103 ปีที่แล้ว +5

    Thank you for your knowledge, I wished you could still see patients

    • @yuyorock
      @yuyorock ปีที่แล้ว +1

      Yes, I hope the same thing. I would pay her anything to take me in as a patient. I can’t find a Dr. willing to help me

  • @LostInThisGardenofLife
    @LostInThisGardenofLife ปีที่แล้ว +5

    Amazing. I wish I would have known about this years ago, thank you so much for sharing.

  • @AgeReversingDoc
    @AgeReversingDoc 8 หลายเดือนก่อน +2

    It was a fantastic interview; I especially loved the conversation about genetics, particularly NRF2 and CBS mutations. Interestingly, 100% of Ruth's patients had CBS Upregulation, which produced more ammonia. I find NRF2 and KEAP1 to be very polymorphic, which, regardless of CBS mutations, will and can increase ammonia production. I am Curious that VDR mutations are common, yet I don't recommend taking more "synthetic Vit D". The VDR receptor needs vitamin A to allow Active Vit D (1,25 OH) into the cell. Taking more synthetic D to boost storage D (25OH) decreases the absorption of Vit A, which then impedes Active D (1,25OH), from getting into the cell. Hence, VDR SNPs do not equal taking more synthetic D. Otherwise, I appreciated everything you had to share.

    • @1dayfree
      @1dayfree 7 หลายเดือนก่อน

      This has got me thinking... If vitamin D deficiency is linked to vitamin a deficiency, is this why carnivore diets are so healing? Is it the vitamin a in liver that is the missing link??

  • @falmouthphotog
    @falmouthphotog ปีที่แล้ว +4

    Excellent. This answered many questions. I am curious which fibrinolytic or biofilm disruptor would be recommended for those with chronic UTIs and Lp(a). Thank you.

  • @lindapelle8738
    @lindapelle8738 ปีที่แล้ว +4

    How do you find a dr who treats Interstitial cyst is with this type of testing?

    • @leearagon3439
      @leearagon3439 9 หลายเดือนก่อน

      My question too

  • @sulj3373
    @sulj3373 10 หลายเดือนก่อน +1

    Great interview thanks.

  • @robbgrice571
    @robbgrice571 ปีที่แล้ว +3

    Are the new PCR molecular testing for UTI better than a standard UTI culture?

    • @samm9773
      @samm9773 ปีที่แล้ว +2

      Yes, pcr/dna tests can detect much lower loads of bacteria (and other pathogens) as well of multiple pathogens whereas standard culture may only show one pathogen, if at all.

  • @sulj3373
    @sulj3373 10 หลายเดือนก่อน

    I’ve had cUTI since early 80’s. On full dose antibiotics last4 years.